This is the most accurate Tirzepatide Dosage Calculator online. Convert your Tirzepatide dose in mg to exact syringe units for compounded vials, Mounjaro, and Zepbound — or reconstitute a lyophilized vial from scratch. Use the Toggle button to change modes. We have also added one-tap dose presets for the full 2.5–15 mg titration.
Compounded / pre-mixed: your vial is already mixed and labeled with a concentration (e.g. 20 mg/mL). Enter concentration + dose to get your units.
Syringe Size
Concentration
Vial Strength
Bacteriostatic Water
Dose
Not medical advice — for education only. This Tirzepatide Dosage Calculator performs a mathematical conversion only and assumes a standard U-100 insulin syringe (100 units = 1 mL). It does not set your dose or confirm any dose is safe, appropriate, or legal for you. Compounded tirzepatide is not FDA-approved. Double-check every number and confirm your dose and vial concentration with your prescriber or pharmacist before drawing or injecting.
How the Tirzepatide Dosage Calculator Works
The Tirzepatide Dosage Calculator above converts a tirzepatide dose in milligrams into the exact number of units to draw on a U-100 insulin syringe. It runs in two modes so it fits every situation. In compounded / pre-mixed mode, you enter the concentration printed on your vial (in mg/mL) and your dose, and the calculator returns your units — the same conversion used for compounded tirzepatide, Mounjaro, and Zepbound. In reconstitution mode, you start from a dry (lyophilized) vial: enter the vial strength in mg and the bacteriostatic water you add, and the Tirzepatide Dosage Calculator works out the concentration for you before converting to units. Most people need the first mode; anyone mixing a research vial from powder needs the second. No other tirzepatide calculator handles both.
The underlying formula is simple and worth understanding, because it is the same math every clinic uses:
Units = (Dose in mg ÷ Concentration in mg/mL) × 100
Based on the U-100 insulin syringe standard, where 100 units = 1 mL.
For example, a 5 mg dose from a 20 mg/mL vial is (5 ÷ 20) × 100 = 25 units. The same 5 mg dose from a 10 mg/mL vial is (5 ÷ 10) × 100 = 50 units. This is why the concentration matters so much: the identical dose can be a completely different number of units depending on how strong your vial is. Copying someone else’s unit count is one of the most common and dangerous mistakes, because their vial may not match yours.
Tirzepatide Dose Chart: mg to Units
This tirzepatide dosage chart shows how many units to draw for each standard dose at the most common compounded concentrations. Find your concentration across the top, your dose down the left side, and read off the units. Any value above 100 units exceeds a 1 mL syringe and needs a larger syringe or a split injection.
| Dose | 5 mg/mL | 10 mg/mL | 15 mg/mL | 20 mg/mL | 34 mg/mL | 40 mg/mL |
|---|---|---|---|---|---|---|
| 2.5 mg | 50 | 25 | 17 | 12.5 | 7.4 | 6.3 |
| 5 mg | 100 | 50 | 33 | 25 | 14.7 | 12.5 |
| 7.5 mg | 150* | 75 | 50 | 37.5 | 22 | 18.8 |
| 10 mg | 200* | 100 | 67 | 50 | 29 | 25 |
| 12.5 mg | 250* | 125* | 83 | 62.5 | 37 | 31.3 |
| 15 mg | 300* | 150* | 100 | 75 | 44 | 37.5 |
*Doses above 100 units exceed a 1 mL syringe and require a larger syringe or a split injection. Values are rounded; use the calculator above for exact figures.
Tirzepatide Titration Schedule (Week by Week)
Tirzepatide is started low and increased slowly to keep gastrointestinal side effects manageable. Everyone begins at 2.5 mg once weekly, and the dose steps up by 2.5 mg roughly every four weeks as tolerated. The standard escalation is the same for compounded tirzepatide and for the brand pens (Mounjaro and Zepbound). Not everyone reaches 15 mg; many people find an effective maintenance dose at 5, 10, or 12.5 mg and stay there.
| Weeks | Weekly Dose | Phase |
|---|---|---|
| Weeks 1–4 | 2.5 mg | Starting dose (not a therapeutic dose) |
| Weeks 5–8 | 5 mg | First maintenance dose |
| Weeks 9–12 | 7.5 mg | Intermediate step |
| Weeks 13–16 | 10 mg | Second maintenance dose |
| Weeks 17–20 | 12.5 mg | Intermediate step |
| Weeks 21+ | 15 mg | Maximum approved dose |
Providers often hold a dose longer than four weeks if appetite control is already good or if side effects need more time to settle. The titration is a guide, not a race — the goal is the lowest dose that gives you results you can sustain. Restarting after a gap usually means re-titrating from a lower dose rather than resuming where you left off, because tolerance to side effects fades.
Compounded vs. Brand Tirzepatide (Mounjaro & Zepbound)
Brand-name tirzepatide comes as Mounjaro (for type 2 diabetes) and Zepbound (for weight management), both delivered in pre-filled single-dose pens that require no measuring. Compounded tirzepatide is dispensed as a vial and syringe, which is exactly why a Tirzepatide Dosage Calculator is needed: you have to convert your prescribed mg dose into units yourself. The table below summarizes the practical differences.
| Brand (Mounjaro / Zepbound) | Compounded | |
|---|---|---|
| FDA approved | Yes | No |
| Delivery | Pre-filled pen | Vial + syringe |
| Dose calculation | Not needed | Required (use the calculator) |
| Dose strengths | 2.5–15 mg fixed pens | Varies by concentration |
What Results Can You Expect?
The pivotal SURMOUNT-1 trial followed 2,539 adults with obesity for 72 weeks. Average weight loss was about 15% of body weight at the 5 mg maintenance dose, roughly 20% at 10 mg, and about 22.5% at the 15 mg maximum dose. These are averages from a supervised trial with diet and activity support — some people lost more than 25%, others closer to 10%. Your own results depend on your starting weight, the dose you can tolerate, and your diet and activity habits. Tirzepatide has a half-life of about five days, which is why it is dosed once weekly and why levels build up gradually over the first several weeks.
How to Inject Compounded Tirzepatide
Brand pens come with their own instructions. For a compounded vial and syringe, the general steps are: wash your hands, check that the liquid is clear and not cloudy, and clean the vial stopper with an alcohol swab. Draw your calculated number of units into a U-100 insulin syringe, tap out air bubbles, and clean the injection site. Inject subcutaneously into the abdomen (at least two inches from the navel), the front of the thigh, or the back of the upper arm, rotating sites each week to avoid lumpy skin. Store compounded vials refrigerated at 2–8°C, use within the timeframe your pharmacy specifies (commonly 28–30 days after first puncture), and never freeze. Always follow the specific instructions from your prescriber or pharmacy over any general guide.
Common Mistakes to Avoid
Three errors cause most dosing problems. First, confusing mg/mL with mg/0.5mL: if your vial says “5 mg/0.5 mL,” that is actually 10 mg/mL — double the number before you enter it. Second, using the wrong syringe: this calculator assumes a U-100 insulin syringe, and a U-40 syringe has entirely different markings that will give the wrong dose. Third, reusing someone else’s unit count: units only translate to a dose if the concentration matches, so always recalculate when you get a new vial, especially after switching pharmacies. When in doubt, confirm the concentration on your label and re-run the Tirzepatide Dosage Calculator.
Tirzepatide Dosage Calculator: Frequently Asked Questions
How many units is 2.5 mg of tirzepatide?
How many units is 5 mg of tirzepatide?
How many units is 7.5 mg of tirzepatide?
How many mg is 40 units of tirzepatide?
How many mg is 50 units of tirzepatide?
What concentrations do compounded tirzepatide vials come in?
What is the difference between mg/mL and mg/0.5 mL?
Why does my dose need more than 100 units?
What is the starting dose of tirzepatide?
Is it safe to stay on 2.5 mg tirzepatide for weight loss?
Is tirzepatide the same as Ozempic?
What does the drug tirzepatide do?
What are the negative side effects of tirzepatide?
Who cannot take tirzepatide?
Is tirzepatide safer than Ozempic?
How long does it take to lose 20 pounds on tirzepatide?
How much weight can I lose in 2 months on tirzepatide?
What syringe should I use for tirzepatide injections?
How should I store compounded tirzepatide?
Sources & References
1. Calculation formula: Units = (Dose mg ÷ Concentration mg/mL) × 100, based on the U-100 insulin syringe standard (100 units = 1 mL).
2. FDA Zepbound Prescribing Information
3. FDA Mounjaro Prescribing Information
4. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216
Resources
Explore every free tool and reference on Bio Peptide Calculator. Start with the main Peptide Calculator: Reconstitution and Dosage Calculator, browse the hubs, or jump straight to a compound-specific calculator or dosing chart.
Dosage Calculators
Dosage Charts
More From Bio Peptide Calculator
Resources & Further Reading
Authoritative sources on tirzepatide dosing, efficacy, and safety. Always follow the guidance of your prescriber and the official prescribing information for your specific product.
Official FDA Prescribing Information
- FDA Zepbound (tirzepatide) Prescribing Information — the official label for tirzepatide approved for chronic weight management.
- FDA Mounjaro (tirzepatide) Prescribing Information — the official label for tirzepatide approved for type 2 diabetes.
Manufacturer (Eli Lilly) Pages
- Lilly: Mounjaro & Zepbound (tirzepatide) Information — the manufacturer’s official overview of both brand-name tirzepatide products, including safety information.
- Lilly: SURMOUNT-1 Results Announcement — Eli Lilly’s summary of the pivotal SURMOUNT-1 obesity trial results (16.0%–22.5% average weight loss).
Peer-Reviewed Studies (PubMed / NEJM)
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022 — the landmark phase 3 trial in 2,539 adults establishing tirzepatide’s weight-loss efficacy at 5, 10, and 15 mg.
- Jastreboff AM, et al. Tirzepatide for Obesity Treatment and Diabetes Prevention. N Engl J Med. 2025 — three-year safety outcomes and diabetes-prevention data from the SURMOUNT-1 population.
- SURMOUNT-3: Tirzepatide after Intensive Lifestyle Intervention. Nat Med. 2023 — efficacy of tirzepatide following a lifestyle-intervention lead-in period.
- Will Tirzepatide Become a Game-Changer Anti-Obesity Drug? (Review) — an open-access review comparing tirzepatide dosing and outcomes with semaglutide.
General Medical References
- Mayo Clinic: Tirzepatide (Subcutaneous Route) — plain-language overview of tirzepatide uses, dosing, and side effects.
- Wikipedia: Tirzepatide — general background on the molecule, mechanism (dual GIP/GLP-1 agonist), approvals, and brand names.
- Drugs.com: Tirzepatide — consumer drug information covering dosage forms, interactions, and warnings.
Note: These resources are for education only. Compounded tirzepatide is not FDA-approved. Always confirm your dose, concentration, and injection technique with your prescriber or pharmacist before use.